Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Protirelin 200micrograms/2ml solution for injection ampoules
0605010R0AAAAAA
|
Protirelin | Protirelin | Endocrine System | No data available |
|
Prowess capsules
060402000BPAAAA
|
Proprietary compound preparation BNF 0604020 | Other male sex hormone and antagonist preparations | Endocrine System | No data available |
|
Puregon 100units/0.5ml solution for injection vials
0605010K0BBAEAE
|
Puregon | Follitropin beta | Endocrine System | No data available |
|
Puregon 150units/0.5ml solution for injection vials
0605010K0BBAFAF
|
Puregon | Follitropin beta | Endocrine System | No data available |
|
Puregon 200units/0.5ml solution for injection vials
0605010K0BBAGAG
|
Puregon | Follitropin beta | Endocrine System | No data available |
|
Puregon 300units/0.36ml solution for injection cartridges
0605010K0BBAHAH
|
Puregon | Follitropin beta | Endocrine System | No data available |
|
Puregon 50units/0.5ml solution for injection vials
0605010K0BBADAD
|
Puregon | Follitropin beta | Endocrine System | No data available |
|
Puregon 600units/0.72ml solution for injection cartridges
0605010K0BBAIAI
|
Puregon | Follitropin beta | Endocrine System | No data available |
|
Puregon 900units/1.08ml solution for injection cartridges
0605010K0BBAJAJ
|
Puregon | Follitropin beta | Endocrine System | No data available |
|
Razylan 60mg tablets
0604011X0BDAAAA
|
Razylan | Raloxifene hydrochloride | Endocrine System | No data available |
|
Rekovelle 12micrograms/0.36ml inj cartridges
0605010AFBBAAAA
|
Rekovelle | Follitropin delta | Endocrine System | No data available |
|
Rekovelle 12micrograms/0.36ml inj pre-filled pens
0605010AFBBADAD
|
Rekovelle | Follitropin delta | Endocrine System | No data available |
|
Rekovelle 36micrograms/1.08ml inj cartridges
0605010AFBBABAB
|
Rekovelle | Follitropin delta | Endocrine System | No data available |
|
Rekovelle 36micrograms/1.08ml inj pre-filled pens
0605010AFBBAFAF
|
Rekovelle | Follitropin delta | Endocrine System | No data available |
|
Rekovelle 72micrograms/2.16ml inj cartridges
0605010AFBBACAC
|
Rekovelle | Follitropin delta | Endocrine System | No data available |
|
Rekovelle 72micrograms/2.16ml inj pre-filled pens
0605010AFBBAEAE
|
Rekovelle | Follitropin delta | Endocrine System | No data available |
|
Restandol 40mg capsules
0604020T0BBAAAA
|
Restandol | Testosterone undecanoate | Endocrine System | No data available |
|
Risedronate sodium 35mg/5ml oral liquid
0606020R0AAAEAE
|
Risedronate sodium | Risedronate sodium | Endocrine System | No data available |
|
Romosozumab 105mg/1.17ml inj pre-filled disposable devices
0606020AAAAAAAA
|
Romosozumab | Romosozumab | Endocrine System | No data available |
|
Rosiglitazone 1mg / Metformin 500mg tablets
0601023V0AAAAAA
|
Metformin hydrochloride/rosiglitazone | Metformin hydrochloride/rosiglitazone | Endocrine System | No data available |
|
Rosiglitazone 2mg / Metformin 1g tablets
0601023V0AAADAD
|
Metformin hydrochloride/rosiglitazone | Metformin hydrochloride/rosiglitazone | Endocrine System | No data available |
|
Rosiglitazone 2mg / Metformin 500mg tablets
0601023V0AAABAB
|
Metformin hydrochloride/rosiglitazone | Metformin hydrochloride/rosiglitazone | Endocrine System | No data available |
|
Rosiglitazone 4mg / Metformin 1g tablets
0601023V0AAACAC
|
Metformin hydrochloride/rosiglitazone | Metformin hydrochloride/rosiglitazone | Endocrine System | No data available |
|
Rosiglitazone 8mg tablets
0601023S0AAABAB
|
Rosiglitazone | Rosiglitazone | Endocrine System | No data available |
|
Roxadin 1000mg/4ml solution for injection vials
0604020T0BEAAAD
|
Roxadin | Testosterone undecanoate | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.